PTPN22 splice forms: a new role in rheumatoid arthritis
Genome Medicine2012Vol. 4(2), pp. 13–13
Citations Over Time
Abstract
Genetic variation in the protein tyrosine phosphatase non-receptor type gene 22 (PTPN22, encoding lymphoid tyrosine phosphatase, LYP) influences the risk of developing multiple autoimmune diseases, but the underlying mechanisms are not completely understood. In a recent study published in Genome Medicine, Ronninger et al. showed that there are differences in the expression of PTPN22 isoforms between peripheral blood mononuclear cells from rheumatoid arthritis patients and those of healthy controls. This study provides new insights into the role of PTPN22 in autoimmune diseases.
Related Papers
- → The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity(2012)59 cited
- → Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases(2010)55 cited
- → Are other protein tyrosine phosphatases than PTPN22 associated with autoimmunity?(2006)20 cited
- → PTPN22 splice forms: a new role in rheumatoid arthritis(2012)16 cited